Blue Water Life Science Advisors, LP
Follow13F filer, CIK 1789778, LARKSPUR, CA
Blue Water Life Science Advisors, LP reported $109,602,298 across 7 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-003275
- Period
- 2025-09-30
- Reported value
- $110M
- Holdings
- 7
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TEMnew | +72,412 | $5.84M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TXGexited | -1,100,720 | -$12.7M |
| AKOYA BIOSCIENCES INC COMexited | -4,697,785 | -$6.11M |
| NTRAreduced | -25,000 | -$4.02M |
| CDNAreduced | -214,014 | -$3.11M |
| GHreduced | -33,400 | -$2.09M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001420506-25-003275, largest first. % of portfolio is the value over $109,602,298, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ADPTADAPTIVE BIOTECHNOLOGIES COR | 2,145,145 | $32.1M | 29.28% | 0 | Timeline | ||
| GHGUARDANT HEALTH INC | 405,647 | $25.3M | 23.12% | -33,400 | Timeline | ||
| NTRANATERA INC | 141,494 | $22.8M | 20.78% | -25,000 | Timeline | ||
| PSNLPERSONALIS INC | 1,676,300 | $10.9M | 9.97% | 0 | Timeline | ||
| CDNACAREDX INC | 510,000 | $7.42M | 6.77% | -214,014 | Timeline | ||
| TEMTEMPUS AI INC | 72,412 | $5.84M | 5.33% | new | Timeline | ||
| QTRXQUANTERIX CORP | 957,747 | $5.2M | 4.74% | 0 | Timeline |
Sold out in Q3 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| TXG10X GENOMICS INC | 1,100,720 | $12.7M | shares |
| AKOYA BIOSCIENCES INC COMAKOYA BIOSCIENCES INC COM | 4,697,785 | $6.11M | shares |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001420506-25-003275 | base | 2025-11-14 | acceptance time not in the bulk data set |